Press Releases

    Print Page  Close Window
BioMed Realty Trust to Report 2013 Fourth Quarter and Year End Results

SAN DIEGO, Jan. 27, 2014 (GLOBE NEWSWIRE) -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced it will report results for its fourth quarter and year ended December 31, 2013 after the market closes on Wednesday, February 5, 2014.

Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, February 6, 2014 to discuss the company's financial results and operations for the year.

The call will be available through a live audio web cast at the Investor Relations section of the company's web site at www.biomedrealty.com and at www.earnings.com, which will include an online slide presentation to accompany the call, or live by calling (800) 708-4539 (domestic) or (847) 619-6396 (international) with call ID number 36559938. The complete webcast will be archived for 30 days on both web sites. A telephone playback of the conference call will also be available from 1:30 p.m. Pacific Time on Thursday, February 6, 2014 until midnight Pacific Time on Tuesday, February 11, 2014 by calling (888) 843-7419 (domestic) or (630) 652-3042 (international) and using access code 36559938#.

About BioMed Realty Trust

BioMed Realty, with its trusted expertise and valuable relationships, delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising approximately 16.3 million rentable square feet. Additional information is available at www.biomedrealty.com. Follow us on Twitter @biomedrealty.

CONTACT: Rick Howe
         Senior Director, Corporate Communications
         (858) 207-5859
         richard.howe@biomedrealty.com
BioMed Realty Trust, Inc.